Bain, Pfizer launch biotech startup to tackle brain disorders

Bain Capital LP and Pfizer Inc. have teamed up to launch a new biotech in the Boston area focused on neurological disorders, including Parkinson ’s and Alzheimer’s disease. The new company, called Cerevel Therapeutics LLC, is starting out with a $350 million investment from funds affiliated with Bain. In a release, Pfizer (NYSE: PFE) and Bain said that Cerevel “will be based in the Greater Boston area,” but did not specify where. F or Pfizer, Tuesday’s announcement marks a return, of sorts,…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news